| pubmed-article:12823646 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12823646 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:12823646 | lifeskim:mentions | umls-concept:C0032659 | lld:lifeskim |
| pubmed-article:12823646 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:12823646 | lifeskim:mentions | umls-concept:C0038454 | lld:lifeskim |
| pubmed-article:12823646 | lifeskim:mentions | umls-concept:C0004057 | lld:lifeskim |
| pubmed-article:12823646 | lifeskim:mentions | umls-concept:C0004238 | lld:lifeskim |
| pubmed-article:12823646 | lifeskim:mentions | umls-concept:C0043031 | lld:lifeskim |
| pubmed-article:12823646 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:12823646 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:12823646 | pubmed:dateCreated | 2003-6-25 | lld:pubmed |
| pubmed-article:12823646 | pubmed:abstractText | To assess the optimal stroke prevention treatment for patients with atrial fibrillation (AF) and a low-medium risk (< or =4%) of stroke. | lld:pubmed |
| pubmed-article:12823646 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12823646 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12823646 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12823646 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12823646 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12823646 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12823646 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12823646 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12823646 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:12823646 | pubmed:issn | 0954-6820 | lld:pubmed |
| pubmed-article:12823646 | pubmed:author | pubmed-author:PehrssonKK | lld:pubmed |
| pubmed-article:12823646 | pubmed:author | pubmed-author:EdvardssonNN | lld:pubmed |
| pubmed-article:12823646 | pubmed:author | pubmed-author:Juul-MöllerSS | lld:pubmed |
| pubmed-article:12823646 | pubmed:author | pubmed-author:OmblusRR | lld:pubmed |
| pubmed-article:12823646 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12823646 | pubmed:volume | 254 | lld:pubmed |
| pubmed-article:12823646 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12823646 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12823646 | pubmed:pagination | 95-101 | lld:pubmed |
| pubmed-article:12823646 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:12823646 | pubmed:meshHeading | pubmed-meshheading:12823646... | lld:pubmed |
| pubmed-article:12823646 | pubmed:meshHeading | pubmed-meshheading:12823646... | lld:pubmed |
| pubmed-article:12823646 | pubmed:meshHeading | pubmed-meshheading:12823646... | lld:pubmed |
| pubmed-article:12823646 | pubmed:meshHeading | pubmed-meshheading:12823646... | lld:pubmed |
| pubmed-article:12823646 | pubmed:meshHeading | pubmed-meshheading:12823646... | lld:pubmed |
| pubmed-article:12823646 | pubmed:meshHeading | pubmed-meshheading:12823646... | lld:pubmed |
| pubmed-article:12823646 | pubmed:meshHeading | pubmed-meshheading:12823646... | lld:pubmed |
| pubmed-article:12823646 | pubmed:meshHeading | pubmed-meshheading:12823646... | lld:pubmed |
| pubmed-article:12823646 | pubmed:meshHeading | pubmed-meshheading:12823646... | lld:pubmed |
| pubmed-article:12823646 | pubmed:meshHeading | pubmed-meshheading:12823646... | lld:pubmed |
| pubmed-article:12823646 | pubmed:meshHeading | pubmed-meshheading:12823646... | lld:pubmed |
| pubmed-article:12823646 | pubmed:meshHeading | pubmed-meshheading:12823646... | lld:pubmed |
| pubmed-article:12823646 | pubmed:meshHeading | pubmed-meshheading:12823646... | lld:pubmed |
| pubmed-article:12823646 | pubmed:meshHeading | pubmed-meshheading:12823646... | lld:pubmed |
| pubmed-article:12823646 | pubmed:meshHeading | pubmed-meshheading:12823646... | lld:pubmed |
| pubmed-article:12823646 | pubmed:meshHeading | pubmed-meshheading:12823646... | lld:pubmed |
| pubmed-article:12823646 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12823646 | pubmed:articleTitle | Effects of low-dose warfarin and aspirin versus no treatment on stroke in a medium-risk patient population with atrial fibrillation. | lld:pubmed |
| pubmed-article:12823646 | pubmed:affiliation | Division of Cardiology, Sahlgrenska University Hospital, Stockholm, Sweden. | lld:pubmed |
| pubmed-article:12823646 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12823646 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:12823646 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:12823646 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:12823646 | pubmed:publicationType | Multicenter Study | lld:pubmed |
